Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals.[ Read More ]
The intrinsic value of one DGX stock under the base case scenario is HIDDEN Compared to the current market price of 160 USD, Quest Diagnostics Incorporated is HIDDEN
Current Assets | 2.37 B |
Cash & Short-Term Investments | 686 M |
Receivables | 1.21 B |
Other Current Assets | 476 M |
Non-Current Assets | 11.6 B |
Long-Term Investments | 135 M |
PP&E | 2.42 B |
Other Non-Current Assets | 9.1 B |
Current Liabilities | 1.82 B |
Accounts Payable | 378 M |
Short-Term Debt | 585 M |
Other Current Liabilities | 852 M |
Non-Current Liabilities | 5.79 B |
Long-Term Debt | 4.91 B |
Other Non-Current Liabilities | 876 M |
Revenue | 9.25 B |
Cost Of Revenue | 6.29 B |
Gross Profit | 2.96 B |
Operating Expenses | 1.61 B |
Operating Income | 1.26 B |
Other Expenses | 412 M |
Net Income | 850 M |
Net Income | 850 M |
Depreciation & Amortization | 439 M |
Capital Expenditures | -408 M |
Stock-Based Compensation | 77 M |
Change in Working Capital | -145 M |
Others | 25 M |
Free Cash Flow | 864 M |
Date | Value | Insider | Amount | Avg Price |
---|---|---|---|---|
1 week ago
Nov 06, 2024
|
Sell 321 K USD
|
DEPPE MICHAEL J
SVP, Corp. Controller & CAO |
- 2100
|
152.7029 USD |
1 week ago
Nov 06, 2024
|
Sell 370 K USD
|
DEPPE MICHAEL J
SVP, Corp. Controller & CAO |
- 2400
|
153.9829 USD |
1 week ago
Nov 06, 2024
|
Sell 640 K USD
|
DEPPE MICHAEL J
SVP, Corp. Controller & CAO |
- 4135
|
154.736 USD |
1 week ago
Nov 06, 2024
|
Sell 397 K USD
|
DEPPE MICHAEL J
SVP, Corp. Controller & CAO |
- 2600
|
152.7115 USD |
1 week ago
Nov 06, 2024
|
Sell 359 K USD
|
DEPPE MICHAEL J
SVP, Corp. Controller & CAO |
- 2331
|
154.031 USD |
1 week ago
Nov 06, 2024
|
Sell 803 K USD
|
DEPPE MICHAEL J
SVP, Corp. Controller & CAO |
- 5189
|
154.7424 USD |
2 weeks ago
Oct 28, 2024
|
Sell 279 K USD
|
KUPPUSAMY KARTHIK
SVP, Clinical Solutions |
- 1775
|
156.9156 USD |
2 months ago
Aug 29, 2024
|
Sell 5.04 M USD
|
PREVOZNIK MICHAEL E
SVP & General Counsel |
- 32551
|
154.9727 USD |
2 months ago
Aug 28, 2024
|
Sell 305 K USD
|
KUPPUSAMY KARTHIK
SVP, Clinical Solutions |
- 1990
|
153.2612 USD |
3 months ago
Jul 24, 2024
|
Sell 60.1 K USD
|
DELANEY MARK E
SVP & Chief Commercial Officer |
- 420
|
143.08 USD |
6 months ago
Apr 29, 2024
|
Sell 246 K USD
|
KUPPUSAMY KARTHIK
SVP, Clinical Solutions |
- 1760
|
140 USD |
8 months ago
Feb 28, 2024
|
Sell 703 K USD
|
Doherty Catherine T.
EVP, Regional Businesses |
- 5557
|
126.57 USD |
8 months ago
Feb 29, 2024
|
Sell 149 K USD
|
Doherty Catherine T.
EVP, Regional Businesses |
- 1187
|
125.88 USD |
8 months ago
Feb 29, 2024
|
Sell 706 K USD
|
PREVOZNIK MICHAEL E
SVP & General Counsel |
- 5611
|
125.88 USD |
8 months ago
Feb 22, 2024
|
Sell 83.4 K USD
|
PREVOZNIK MICHAEL E
SVP & General Counsel |
- 661
|
126.14 USD |
8 months ago
Feb 23, 2024
|
Sell 317 K USD
|
Gregg Vicky B
Director |
- 2500
|
126.6386 USD |
8 months ago
Feb 22, 2024
|
Sell 104 K USD
|
Doherty Catherine T.
EVP, Regional Businesses |
- 821
|
126.14 USD |
1 year ago
Mar 07, 2023
|
Sell 668 K USD
|
PREVOZNIK MICHAEL E
SVP & General Counsel |
- 4754
|
140.55 USD |
1 year ago
Mar 07, 2023
|
Sell 746 K USD
|
Doherty Catherine T.
SVP, Regional Businesses |
- 5307
|
140.55 USD |
1 year ago
Mar 03, 2023
|
Sell 101 K USD
|
Doherty Catherine T.
SVP, Regional Businesses |
- 717
|
140.63 USD |
1 year ago
Mar 02, 2023
|
Sell 82.2 K USD
|
PREVOZNIK MICHAEL E
SVP & General Counsel |
- 593
|
138.54 USD |
1 year ago
Feb 24, 2023
|
Sell 200 K USD
|
PREVOZNIK MICHAEL E
SVP & General Counsel |
- 1415
|
141.42 USD |
1 year ago
Feb 24, 2023
|
Sell 239 K USD
|
Doherty Catherine T.
SVP, Regional Businesses |
- 1690
|
141.42 USD |
1 year ago
Dec 01, 2022
|
Sell 309 K USD
|
RING TIMOTHY M
Director |
- 2025
|
152.5 USD |
1 year ago
Nov 28, 2022
|
Sell 2.58 M USD
|
Doherty Catherine T.
SVP, Regional Businesses |
- 17358
|
148.9153 USD |
1 year ago
Nov 28, 2022
|
Sell 3.5 M USD
|
Doherty Catherine T.
SVP, Regional Businesses |
- 23407
|
149.3737 USD |
2 years ago
Nov 01, 2022
|
Sell 288 K USD
|
RING TIMOTHY M
Director |
- 2000
|
144.06 USD |
2 years ago
Oct 26, 2022
|
Sell 2.25 M USD
|
DEPPE MICHAEL J
VP, Corp. Controller & CAO |
- 15497
|
145 USD |
2 years ago
Oct 03, 2022
|
Sell 247 K USD
|
RING TIMOTHY M
Director |
- 2000
|
123.39 USD |
2 years ago
Sep 01, 2022
|
Sell 250 K USD
|
RING TIMOTHY M
director: |
- 2000
|
125.02 USD |
2 years ago
Aug 01, 2022
|
Sell 272 K USD
|
RING TIMOTHY M
director: |
- 2000
|
136.04 USD |
2 years ago
Jul 01, 2022
|
Sell 267 K USD
|
RING TIMOTHY M
director: |
- 2000
|
133.47 USD |
2 years ago
May 25, 2022
|
Sell 1.38 M USD
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President |
- 9823
|
140.581 USD |
2 years ago
May 25, 2022
|
Sell 959 K USD
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President |
- 6821
|
140.602 USD |
2 years ago
May 25, 2022
|
Sell 584 K USD
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President |
- 4131
|
141.348 USD |
2 years ago
May 25, 2022
|
Sell 363 K USD
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President |
- 2565
|
141.361 USD |
2 years ago
May 25, 2022
|
Sell 92.5 K USD
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President |
- 651
|
142.151 USD |
2 years ago
May 25, 2022
|
Sell 128 K USD
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President |
- 900
|
142.134 USD |
2 years ago
May 23, 2022
|
Sell 5.78 M USD
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President |
- 41268
|
140.119 USD |
2 years ago
May 23, 2022
|
Sell 4.75 M USD
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President |
- 33898
|
140.124 USD |
2 years ago
May 23, 2022
|
Sell 142 K USD
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President |
- 1000
|
141.509 USD |
2 years ago
May 23, 2022
|
Sell 113 K USD
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President |
- 800
|
141.542 USD |
2 years ago
May 23, 2022
|
Sell 42.7 K USD
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President |
- 300
|
142.24 USD |
2 years ago
May 23, 2022
|
Sell 28.5 K USD
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President |
- 200
|
142.255 USD |
2 years ago
May 24, 2022
|
Sell 17.7 M USD
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President |
- 126126
|
140.12 USD |
2 years ago
May 24, 2022
|
Sell 21.9 M USD
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President |
- 156282
|
140.122 USD |
2 years ago
May 17, 2022
|
Sell 7.08 M USD
|
PREVOZNIK MICHAEL E
SVP & General Counsel |
- 50604
|
139.969 USD |
2 years ago
Mar 07, 2022
|
Sell 842 K USD
|
PREVOZNIK MICHAEL E
SVP & General Counsel |
- 6228
|
135.21 USD |
2 years ago
Mar 07, 2022
|
Sell 951 K USD
|
Doherty Catherine T.
SVP, Group Exec. Clin. Fran. |
- 7032
|
135.21 USD |
2 years ago
Feb 28, 2022
|
Sell 85.9 K USD
|
PREVOZNIK MICHAEL E
SVP & General Counsel |
- 661
|
130 USD |
2 years ago
Feb 24, 2022
|
Sell 347 K USD
|
Doherty Catherine T.
SVP, Group Exec. Clin. Fran. |
- 2750
|
126.26 USD |
2 years ago
Feb 24, 2022
|
Sell 211 K USD
|
PREVOZNIK MICHAEL E
SVP & General Counsel |
- 1669
|
126.26 USD |
2 years ago
Nov 29, 2021
|
Sell 46 K USD
|
Doherty Catherine T.
SVP, Group Exec. Clin. Fran. |
- 300
|
153.383 USD |
2 years ago
Nov 29, 2021
|
Sell 503 K USD
|
Doherty Catherine T.
SVP, Group Exec. Clin. Fran. |
- 3250
|
154.792 USD |
2 years ago
Nov 29, 2021
|
Sell 550 K USD
|
Doherty Catherine T.
SVP, Group Exec. Clin. Fran. |
- 3532
|
155.774 USD |
2 years ago
Nov 29, 2021
|
Sell 2.5 M USD
|
Doherty Catherine T.
SVP, Group Exec. Clin. Fran. |
- 15908
|
156.855 USD |
2 years ago
Nov 29, 2021
|
Sell 2.3 M USD
|
Doherty Catherine T.
SVP, Group Exec. Clin. Fran. |
- 14575
|
157.533 USD |
3 years ago
Jul 28, 2021
|
Sell 19.6 M USD
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President |
- 139751
|
140.141 USD |
3 years ago
Jul 29, 2021
|
Sell 745 K USD
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President |
- 5300
|
140.591 USD |
3 years ago
Jul 29, 2021
|
Sell 592 K USD
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President |
- 4193
|
141.216 USD |
3 years ago
Jul 26, 2021
|
Sell 814 K USD
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President |
- 5813
|
140.03 USD |
3 years ago
Jul 27, 2021
|
Sell 4.59 M USD
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President |
- 32788
|
140.007 USD |
3 years ago
Jul 27, 2021
|
Sell 851 K USD
|
WILENSKY GAIL R
Director |
- 6111
|
139.323 USD |
3 years ago
Jul 27, 2021
|
Sell 851 K USD
|
WILENSKY GAIL R
Director |
- 6111
|
139.268 USD |
3 years ago
May 07, 2021
|
Sell 1.19 M USD
|
Doherty Catherine T.
SVP, Group Exec. Clin. Fran. |
- 8536
|
139.963 USD |
3 years ago
May 05, 2021
|
Sell 6.16 M USD
|
PREVOZNIK MICHAEL E
SVP & General Counsel |
- 44939
|
137 USD |
3 years ago
Mar 10, 2021
|
Sell 671 K USD
|
PREVOZNIK MICHAEL E
SVP & General Counsel |
- 5574
|
120.47 USD |
3 years ago
Feb 25, 2021
|
Sell 92.5 K USD
|
PREVOZNIK MICHAEL E
SVP & General Counsel |
- 801
|
115.49 USD |
3 years ago
Feb 24, 2021
|
Sell 51.2 K USD
|
PREVOZNIK MICHAEL E
SVP & General Counsel |
- 438
|
116.95 USD |
3 years ago
Feb 24, 2021
|
Sell 87.7 K USD
|
PREVOZNIK MICHAEL E
SVP & General Counsel |
- 750
|
116.95 USD |
3 years ago
Dec 24, 2020
|
Sell 7.11 M USD
|
GUINAN MARK
Executive Vice President & CFO |
- 59193
|
120.057 USD |
3 years ago
Dec 24, 2020
|
Sell 2.73 M USD
|
GUINAN MARK
Executive Vice President & CFO |
- 22563
|
121.178 USD |
3 years ago
Nov 24, 2020
|
Sell 770 K USD
|
WILENSKY GAIL R
Director |
- 6111
|
126.022 USD |
3 years ago
Nov 23, 2020
|
Sell 707 K USD
|
STANZIONE DANIEL
Director |
- 5621
|
125.7317 USD |
3 years ago
Nov 23, 2020
|
Sell 418 K USD
|
STANZIONE DANIEL
Director |
- 3302
|
126.4639 USD |
3 years ago
Nov 23, 2020
|
Sell 293 K USD
|
STANZIONE DANIEL
Director |
- 2300
|
127.4508 USD |
4 years ago
Oct 21, 2020
|
Sell 712 K USD
|
DEPPE MICHAEL J
VP, Corp. Controller & CAO |
- 5700
|
125 USD |
4 years ago
Oct 21, 2020
|
Sell 594 K USD
|
DEPPE MICHAEL J
VP, Corp. Controller & CAO |
- 4750
|
125 USD |
4 years ago
Oct 16, 2020
|
Sell 35 M USD
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President |
- 291997
|
120 USD |
4 years ago
Oct 14, 2020
|
Sell 4.24 M USD
|
PREVOZNIK MICHAEL E
SVP & General Counsel |
- 35591
|
119 USD |
4 years ago
Sep 02, 2020
|
Sell 6.04 M USD
|
Doherty Catherine T.
SVP, Group Exec. Clin. Fran. |
- 54616
|
110.567 USD |
4 years ago
Sep 02, 2020
|
Sell 420 K USD
|
Doherty Catherine T.
SVP, Group Exec. Clin. Fran. |
- 3776
|
111.127 USD |
4 years ago
Jun 08, 2020
|
Sell 5.35 M USD
|
GUINAN MARK
Executive Vice President & CFO |
- 45826
|
116.811 USD |
4 years ago
Jun 08, 2020
|
Sell 2.15 M USD
|
GUINAN MARK
Executive Vice President & CFO |
- 18246
|
117.649 USD |
4 years ago
Jun 08, 2020
|
Sell 1.01 M USD
|
GUINAN MARK
Executive Vice President & CFO |
- 8524
|
118.604 USD |
4 years ago
Jun 08, 2020
|
Sell 1.37 M USD
|
RING TIMOTHY M
Director |
- 11730
|
116.6 USD |
4 years ago
Apr 27, 2020
|
Sell 1.31 M USD
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President |
- 11717
|
112.011 USD |
4 years ago
Apr 27, 2020
|
Sell 280 K USD
|
EGLINTON MANNER CARRIE
SVP, Advanced Diagnostics |
- 2500
|
112.03 USD |
4 years ago
Apr 27, 2020
|
Sell 275 K USD
|
EGLINTON MANNER CARRIE
SVP, Advanced Diagnostics |
- 2500
|
110 USD |
4 years ago
Mar 16, 2020
|
Sell 17.1 K USD
|
Davis J. E.
EVP, General Diagnostics |
- 200
|
85.59 USD |
4 years ago
Mar 16, 2020
|
Sell 94 K USD
|
Davis J. E.
EVP, General Diagnostics |
- 1085
|
86.654 USD |
4 years ago
Mar 16, 2020
|
Sell 115 K USD
|
Davis J. E.
EVP, General Diagnostics |
- 1307
|
87.813 USD |
4 years ago
Mar 16, 2020
|
Sell 37.3 K USD
|
Davis J. E.
EVP, General Diagnostics |
- 421
|
88.525 USD |
4 years ago
Mar 16, 2020
|
Sell 45.1 K USD
|
Davis J. E.
EVP, General Diagnostics |
- 500
|
90.146 USD |
4 years ago
Mar 11, 2020
|
Sell 227 K USD
|
PREVOZNIK MICHAEL E
SVP & General Counsel |
- 2175
|
104.25 USD |
4 years ago
Mar 11, 2020
|
Sell 261 K USD
|
Doherty Catherine T.
SVP, Group Exec. Clin. Fran. |
- 2501
|
104.25 USD |
4 years ago
Mar 10, 2020
|
Sell 11.2 K USD
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President |
- 100
|
112.19 USD |
4 years ago
Mar 06, 2020
|
Sell 19.2 M USD
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President |
- 171025
|
112.207 USD |
4 years ago
Mar 06, 2020
|
Sell 4.18 M USD
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President |
- 36790
|
113.652 USD |
4 years ago
Mar 06, 2020
|
Sell 1.88 M USD
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President |
- 16426
|
114.236 USD |
4 years ago
Mar 06, 2020
|
Sell 455 K USD
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President |
- 3937
|
115.452 USD |
4 years ago
Mar 06, 2020
|
Sell 233 K USD
|
RUSCKOWSKI STEPHEN H
Chairman, CEO and President |
- 2000
|
116.272 USD |
4 years ago
Feb 26, 2020
|
Sell 35.7 K USD
|
PREVOZNIK MICHAEL E
SVP & General Counsel |
- 321
|
111.09 USD |
4 years ago
Feb 27, 2020
|
Sell 75.2 K USD
|
PREVOZNIK MICHAEL E
SVP & General Counsel |
- 690
|
109.02 USD |
4 years ago
Feb 26, 2020
|
Sell 40.9 K USD
|
Doherty Catherine T.
SVP, Group Exec. Clin. Fran. |
- 368
|
111.09 USD |
4 years ago
Feb 27, 2020
|
Sell 86 K USD
|
Doherty Catherine T.
SVP, Group Exec. Clin. Fran. |
- 789
|
109.02 USD |
4 years ago
Feb 26, 2020
|
Sell 56.7 K USD
|
Davis J. E.
EVP, General Diagnostics |
- 510
|
111.09 USD |
4 years ago
Feb 27, 2020
|
Sell 120 K USD
|
Davis J. E.
EVP, General Diagnostics |
- 1100
|
109.02 USD |
4 years ago
Feb 25, 2020
|
Sell 67.4 K USD
|
Davis J. E.
EVP, General Diagnostics |
- 598
|
112.73 USD |
4 years ago
Feb 25, 2020
|
Sell 45.7 K USD
|
Doherty Catherine T.
SVP, Group Exec. Clin. Fran. |
- 405
|
112.73 USD |
4 years ago
Jan 02, 2020
|
Sell 6.14 M USD
|
Davis J. E.
EVP, General Diagnostics |
- 58258
|
105.458 USD |
4 years ago
Jan 02, 2020
|
Sell 791 K USD
|
Davis J. E.
EVP, General Diagnostics |
- 7423
|
106.513 USD |
4 years ago
Jan 02, 2020
|
Sell 7.28 M USD
|
Davis J. E.
EVP, General Diagnostics |
- 69003
|
105.452 USD |
4 years ago
Jan 02, 2020
|
Sell 943 K USD
|
Davis J. E.
EVP, General Diagnostics |
- 8853
|
106.511 USD |
4 years ago
Nov 27, 2019
|
Sell 1.27 M USD
|
PREVOZNIK MICHAEL E
SVP & General Counsel |
- 11863
|
107.148 USD |